
Eric Olson
Examiner (ID: 2127)
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 1713 |
| Issued Applications | 963 |
| Pending Applications | 131 |
| Abandoned Applications | 631 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10819729
[patent_doc_number] => 20160165888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'PEST CONTROL COMPOSITION INCLUDING NOVEL IMINOPYRIDINE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 15/051730
[patent_app_country] => US
[patent_app_date] => 2016-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 72757
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15051730
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/051730 | Pest control composition including novel iminopyridine derivative | Feb 23, 2016 | Issued |
Array
(
[id] => 15008453
[patent_doc_number] => 10450342
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Method for solution phase detritylation of oligomeric compounds
[patent_app_type] => utility
[patent_app_number] => 15/552890
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11436
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 136
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552890
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/552890 | Method for solution phase detritylation of oligomeric compounds | Feb 22, 2016 | Issued |
Array
(
[id] => 16353102
[patent_doc_number] => 10793603
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Polysaccharide derivative having membrane-permeable peptide chain
[patent_app_type] => utility
[patent_app_number] => 15/547595
[patent_app_country] => US
[patent_app_date] => 2016-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6069
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 292
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15547595
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/547595 | Polysaccharide derivative having membrane-permeable peptide chain | Feb 22, 2016 | Issued |
Array
(
[id] => 12527853
[patent_doc_number] => 10006131
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2018-06-26
[patent_title] => Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array
[patent_app_type] => utility
[patent_app_number] => 15/050377
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13663
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15050377
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/050377 | Electrochemical deblocking solution for electrochemical oligomer synthesis on an electrode array | Feb 21, 2016 | Issued |
Array
(
[id] => 14326609
[patent_doc_number] => 10294308
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-21
[patent_title] => Method for isolation of polysaccharides
[patent_app_type] => utility
[patent_app_number] => 15/551531
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 6158
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551531
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551531 | Method for isolation of polysaccharides | Feb 16, 2016 | Issued |
Array
(
[id] => 14913595
[patent_doc_number] => 10428104
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-01
[patent_title] => Substituted nucleoside derivatives useful as anticancer agents
[patent_app_type] => utility
[patent_app_number] => 15/045679
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56169
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15045679
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/045679 | Substituted nucleoside derivatives useful as anticancer agents | Feb 16, 2016 | Issued |
Array
(
[id] => 10805378
[patent_doc_number] => 20160151536
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-02
[patent_title] => 'METHODS OF USE OF BIOMATERIAL AND INJECTABLE IMPLANT CONTAINING BIOMATERIAL'
[patent_app_type] => utility
[patent_app_number] => 15/016914
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3646
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15016914
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/016914 | METHODS OF USE OF BIOMATERIAL AND INJECTABLE IMPLANT CONTAINING BIOMATERIAL | Feb 4, 2016 | Abandoned |
Array
(
[id] => 11323789
[patent_doc_number] => 20160354400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'NUCLEOSIDE PHOSPHORAMIDATES'
[patent_app_type] => utility
[patent_app_number] => 15/016828
[patent_app_country] => US
[patent_app_date] => 2016-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 40572
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15016828
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/016828 | NUCLEOSIDE PHOSPHORAMIDATES | Feb 4, 2016 | Abandoned |
Array
(
[id] => 10789988
[patent_doc_number] => 20160136144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 15/008646
[patent_app_country] => US
[patent_app_date] => 2016-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 33819
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15008646
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/008646 | COMBINATION THERAPY USING 1-AMINOCYCLOHEXANE DERIVATIVES AND ACETYLCHOLINESTERASE INHIBITORS | Jan 27, 2016 | Abandoned |
Array
(
[id] => 15664129
[patent_doc_number] => 10596272
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-24
[patent_title] => Vaccines against
[patent_app_type] => utility
[patent_app_number] => 15/580069
[patent_app_country] => US
[patent_app_date] => 2016-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 32616
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 258
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15580069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/580069 | Vaccines against | Jan 25, 2016 | Issued |
Array
(
[id] => 10790046
[patent_doc_number] => 20160136200
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-19
[patent_title] => 'GASTROINTESTINAL HEALTH, IMMUNITY AND PERFORMANCE BY DIETARY INTERVENTION'
[patent_app_type] => utility
[patent_app_number] => 15/005590
[patent_app_country] => US
[patent_app_date] => 2016-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 17377
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15005590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/005590 | GASTROINTESTINAL HEALTH, IMMUNITY AND PERFORMANCE BY DIETARY INTERVENTION | Jan 24, 2016 | Abandoned |
Array
(
[id] => 14594119
[patent_doc_number] => 10350236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Chondroitin sulfate derivative and agent for treating bladder diseases
[patent_app_type] => utility
[patent_app_number] => 15/542226
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 11796
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542226 | Chondroitin sulfate derivative and agent for treating bladder diseases | Jan 7, 2016 | Issued |
Array
(
[id] => 10760617
[patent_doc_number] => 20160106770
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'EPIGENETIC MECHANISMS OF ANTI-FIBROTIC ACTION FOR THE LIVER'
[patent_app_type] => utility
[patent_app_number] => 14/987365
[patent_app_country] => US
[patent_app_date] => 2016-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12190
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14987365
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/987365 | EPIGENETIC MECHANISMS OF ANTI-FIBROTIC ACTION FOR THE LIVER | Jan 3, 2016 | Abandoned |
Array
(
[id] => 10760615
[patent_doc_number] => 20160106769
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'COMPOUNDS AND METHODS FOR ENHANCING ERYTHROPOIESIS'
[patent_app_type] => utility
[patent_app_number] => 14/980264
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6444
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14980264
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/980264 | Compounds and methods for enhancing erythropoiesis | Dec 27, 2015 | Issued |
Array
(
[id] => 11269210
[patent_doc_number] => 20160331758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-17
[patent_title] => 'TOLL-LIKE RECEPTOR AGONIST FORMULATIONS AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/977129
[patent_app_country] => US
[patent_app_date] => 2015-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17829
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14977129
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/977129 | TOLL-LIKE RECEPTOR AGONIST FORMULATIONS AND THEIR USE | Dec 20, 2015 | Abandoned |
Array
(
[id] => 13167941
[patent_doc_number] => 10100074
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-16
[patent_title] => Regioselective silyl exchange of per-silylated oligosaccharides
[patent_app_type] => utility
[patent_app_number] => 14/975537
[patent_app_country] => US
[patent_app_date] => 2015-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 14424
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14975537
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/975537 | Regioselective silyl exchange of per-silylated oligosaccharides | Dec 17, 2015 | Issued |
Array
(
[id] => 15392941
[patent_doc_number] => 10537103
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Antibacterial composition containing an isomer mixture of monosaccharide alkyl monoacetals or monoethers
[patent_app_type] => utility
[patent_app_number] => 15/537869
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12365
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15537869
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/537869 | Antibacterial composition containing an isomer mixture of monosaccharide alkyl monoacetals or monoethers | Dec 16, 2015 | Issued |
Array
(
[id] => 13702781
[patent_doc_number] => 20170362345
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => POLYMERIC BLEND CONTAINING POLY ALPHA-1,3-GLUCAN
[patent_app_type] => utility
[patent_app_number] => 15/533414
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11940
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15533414
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/533414 | Polymeric blend containing poly alpha-1,3-glucan | Dec 16, 2015 | Issued |
Array
(
[id] => 10754969
[patent_doc_number] => 20160101122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-14
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING SPINOCEREBELLAR ATAXIA'
[patent_app_type] => utility
[patent_app_number] => 14/973465
[patent_app_country] => US
[patent_app_date] => 2015-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10966
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14973465
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/973465 | COMPOSITIONS AND METHODS FOR TREATING SPINOCEREBELLAR ATAXIA | Dec 16, 2015 | Abandoned |
Array
(
[id] => 14388509
[patent_doc_number] => 10307512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-04
[patent_title] => Process for preparing hydrogels
[patent_app_type] => utility
[patent_app_number] => 15/536039
[patent_app_country] => US
[patent_app_date] => 2015-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8810
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15536039
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/536039 | Process for preparing hydrogels | Dec 14, 2015 | Issued |